Open AccessArterial steroid injection therapy can inhibit the progression of severe acute hepatic failure toward fulminant liver failure
Author(s) -
Kazuhiro Kotoh
Publication year - 2006
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v12.i41.6678
Subject(s) - medicine , fulminant hepatic failure , prothrombin time , ascites , liver transplantation , methylprednisolone , gastroenterology , univariate analysis , liver function tests , liver function , surgery , transplantation , multivariate analysis
To utilize transcatheter arterial steroid injection therapy (TASIT) via the hepatic artery to reduce hepatic macrophage activity in patients with severe acute hepatic failure.